1 Carrié S, Anderson TA. Volatile anesthetics for status asthmaticus in pediatric patients: A comprehensive review and case series. Paediatr Anaesth. 2015;25(5):460–7.
2 Ng D, Fahimi J, Hern HG. Sevoflurane administration initiated out of the ED for life-threatening status asthmaticus. The American Journal of Emergency Medicine. 2015;33(8):1110.e3-1110.e6.
3 Shutes B, Frazier WJ, Tobias JD. An unusual complication with the administration of a volatile anesthetic agent for status asthmaticus in the pediatric intensive care unit: case report and review of the literature. J Intensive Care Med. 2017;32(6):400–4.
4 Expert panel report 3: Guidelines for the diagnosis and management of asthma (Internet). National Heart, Lung, and Blood Institute (US); 2007 (cited 2018 Oct 24.
https://www.ncbi.nlm.nih.gov/books/NBK7232/
5 Tobias JD. Inhalational anesthesia: Basic pharmacology, end organ effects, and applications in the treatment of status asthmaticus. Journal of Intensive Care Medicine. 2009;24(6):361–71.
6 Kim HY, Lee JE, Kim HY, Kim J. Volatile sedation in the intensive care unit: A systematic review and meta-analysis. Medicine (Baltimore). 2017;96(49).
7 Jabaudon M, Boucher P, Imhoff E, Chabanne R, Faure J, Thibault S, et al. Sevoflurane for sedation in acute respiratory distress syndrome. A randomized controlled pilot study. Am J Respir Crit Care Med. 2017;195(6):792–800.
8 Conno ED, Steurer MP, Wittlinger M, Zalunardo MP, Weder W, Schneiter D, et al. Anesthetic-induced improvement of the inflammatory response to one-lung ventilation. Anesthes. 2009;110(6):1316–26.
9 Beck-Schimmer B, Bonvini JM, Braun J, Seeberger M, Neff TA, Risch TJ, et al. Which anesthesia regimen is best to reduce morbidity and mortality in lung surgery? A multicenter randomized controlled trial. Anesthes. 20161;125(2):313–21.
10 Misra S, Koshy T. A review of the practice of sedation with inhalational anaesthetics in the intensive care unit with the AnaConDa® device. Indian J Anaesth. 2012;56(6):518–23.
11 Farrell R, Oomen G, Carey P. A technical review of the history, development and performance of the Anaesthetic Conserving Device «AnaConDa®» for delivering volatile anaesthetic in intensive and post-operative critical care. J Clin Monit Comput. 2018;32(4):595–604.
12 Sturesson L, Bodelsson M, Johansson A, Jonson B, Malmkvist G. Apparent dead space with the Anesthetic Conserving Device, AnaConDa®: A clinical and laboratory investigation. Anesthesia and analgesia. 2013;117(6):1319–24.